OptiNose Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

OptiNose Stock Summary

OptiNose competes with Collegium Pharmaceutical, Phibro Animal, ANI Pharmaceuticals, Procaps Group, and Silver Spike. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.

OptiNose Key Financial Ratios

OptiNose Key Balance Sheet Accounts

OptiNose Key Income Statement Accounts

OptiNose Key Cash Accounts

OptiNose Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining OptiNose's current stock value. Our valuation model uses many indicators to compare OptiNose value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OptiNose competition to find correlations between indicators driving OptiNose's intrinsic value. More Info.OptiNose is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, OptiNose's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OptiNose's earnings, one of the primary drivers of an investment's value.

OptiNose Systematic Risk

Today, most investors in OptiNose Stock are looking for potential investment opportunities by analyzing not only static indicators but also various OptiNose's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of OptiNose growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of OptiNose help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OptiNose. We use our internally-developed statistical techniques to arrive at the intrinsic value of OptiNose based on widely used predictive technical indicators. In general, we focus on analyzing OptiNose Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OptiNose's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.